Total Equity - Newron Pharmaceuticals SpA (SIX:NWRN) - Alpha Spread

Newron Pharmaceuticals SpA
SIX:NWRN

Watchlist Manager
Newron Pharmaceuticals SpA Logo
Newron Pharmaceuticals SpA
SIX:NWRN
Watchlist
Price: 7.66 CHF -3.04%
Market Cap: 145.9m CHF
Have any thoughts about
Newron Pharmaceuticals SpA?
Write Note

Newron Pharmaceuticals SpA
Total Equity

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
|

Newron Pharmaceuticals SpA
Total Equity Peer Comparison

Comparables:
REC
P
PRL
FCM
SHE

Competitive Total Equity Analysis
Latest Figures & CAGR of Competitors

Company Total Equity CAGR 3Y CAGR 5Y CAGR 10Y
Newron Pharmaceuticals SpA
SIX:NWRN
Total Equity
-€29.9m
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Recordati Industria Chimica e Farmaceutica SpA
MIL:REC
Total Equity
€1.8B
CAGR 3-Years
11%
CAGR 5-Years
11%
CAGR 10-Years
9%
P
Pierrel SpA
MIL:PRL
Total Equity
€25.8m
CAGR 3-Years
20%
CAGR 5-Years
59%
CAGR 10-Years
N/A
Friulchem SpA
MIL:FCM
Total Equity
€10.1m
CAGR 3-Years
-1%
CAGR 5-Years
10%
CAGR 10-Years
N/A
Shedir Pharma Srl Unipersonale
MIL:SHE
Total Equity
€36m
CAGR 3-Years
10%
CAGR 5-Years
6%
CAGR 10-Years
N/A

See Also

What is Newron Pharmaceuticals SpA's Total Equity?
Total Equity
-29.9m EUR

Based on the financial report for Dec 31, 2023, Newron Pharmaceuticals SpA's Total Equity amounts to -29.9m EUR.

What is Newron Pharmaceuticals SpA's Total Equity growth rate?
Total Equity CAGR 1Y
-113%

Over the last year, the Total Equity growth was -113%.

Back to Top